Nilotinib for the Treatment of Chronic Myeloid Leukemia: An Evidence-Based Review

Core Evidence - New Zealand
doi 10.2147/ce.s6003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy